Founded in 2012, CapitalBio Technology Co., Ltd. is a leading life science company and the industrialisation platform of CapitalBio Corporation and the Beijing National Engineering Research Center for Biochips. Headquartered in Beijing, China, it develops and commercialises healthcare solutions, including biochip-based automation platforms and life science instruments. Its core products include microarray scanners, microfluidic chip analyzers, biochip hybridisation stations, DNA sequencers, and genetic testing kits for applications in genomics, proteomics, and clinical diagnostics. Serving industries such as healthcare, agriculture, and food safety, CapitalBio supports clients such as biomedical researchers and clinicians with solutions for infectious disease detection, fetal chromosomal aneuploidy screening, and HPV genotyping. The company operates worldwide, with certifications such as ISO9001 and CNASL2451, and has strategic partnerships with firms such as Affymetrix and Roche NimbleGen. CapitalBio's innovations, including its electromagnetic biochip, have earned awards such as the National Technology Invention Award's Second Prize.